Ivabradine (Procoralan, Servier Laboratories) is a heart-rate-lowering agent that selectively and specifically inhibits..
The current estimate of the prevalence of atrial fibrillation (AF) in the developed world is approximately 1.5–2% of the..
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationAug 2012
The management of acute myocardial infarction continues to undergo major changes. Good practice should be based on sound..
Myocardial infarction (MI) can be recognised by clinical features, including electrocardiographic (ECG) findings,..
Lower limb peripheral arterial disease (called peripheral arterial disease throughout this document) is a marker for..
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testingJun 2012
The current standard practice for the treatment of VTE is anticoagulation. These drugs “thin” the blood and prevent..
The aim of this document is to provide practical guidelines for the diagnosis, assessment, and treatment of acute and..
This guideline focuses on the use of Apixaban for prevention of venous thromboembolism after total hip or knee..
European Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationNov 2011
The present document deals with the management of patients with suspected NSTE-ACS...
This guideline covers the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours in..
This guideline offers best practice advice on the care of people with stable angina...
Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower..
The guideline identifies adult patient groups at risk of VTE and describes the available methods of prophylaxis...
Formulation of the best possible revascularization approach, taking into consideration the social and cultural context..
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population...
Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospitalJan 2010
This guideline examines the risk of venous thromboembolism and assesses the evidence for the effectiveness of primary..
Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospitalJan 2010
This guidance is about the care and treatment of people who are at risk of developing deep vein thrombosis (DVT) while..
An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC..
The aim of the present Task Force was to review the strength of evidence to support these interventions and the..
Post Myocardial Infarction: Secondary prevention in primary and secondary care for patients following a myocardial infarctionMay 2007
This guideline is very welcome as it clearly emphasises the importance of exercise, smoking habit, diet and cardiac..
This guideline sets out best practice for the diagnosis and treatment of AF in both primary and secondary care. It also..